These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 19091433

  • 1. Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan.
    Liu YM, Yang YH, Hsieh CR.
    J Health Econ; 2009 Mar; 28(2):341-9. PubMed ID: 19091433
    [Abstract] [Full Text] [Related]

  • 2. Choice of generic versus brand-name antidepressants in a regulated prescription drug market: evidence from Taiwan.
    Liu YM, Ou HT, Yang YK.
    J Ment Health Policy Econ; 2014 Dec; 17(4):163-72. PubMed ID: 25599280
    [Abstract] [Full Text] [Related]

  • 3. The importance of the physician in the generic versus trade-name prescription decision.
    Hellerstein JK.
    Rand J Econ; 1998 Dec; 29(1):108-36. PubMed ID: 10182437
    [Abstract] [Full Text] [Related]

  • 4. Brand name or generic? What are the health professionals prescribed for treating diabetes? A longitudinal analysis of the National Health Insurance reimbursement database.
    Liou WS, Hsieh SC, Chang WY, Wu GH, Huang HS, Lee C.
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):752-9. PubMed ID: 23625864
    [Abstract] [Full Text] [Related]

  • 5. Changes in prescribing behaviors after implementing drug reimbursement rate reduction policy in Taiwan: implications for the medicare system.
    Chu HL, Liu SZ, Romeis JC.
    J Health Care Finance; 2008 Jul; 34(3):45-54. PubMed ID: 18468378
    [Abstract] [Full Text] [Related]

  • 6. Delivering generics without regulatory incentives? Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names.
    Paraponaris A, Verger P, Desquins B, Villani P, Bouvenot G, Rochaix L, Gourheux JC, Moatti JP, Panel MG Paca.
    Health Policy; 2004 Oct; 70(1):23-32. PubMed ID: 15312707
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?
    Granlund D.
    Soc Sci Med; 2009 Dec; 69(11):1643-50. PubMed ID: 19815322
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An unhealthy public-private tension: pharmacy ownership, prescribing, and spending in the Philippines.
    James CD, Peabody J, Solon O, Quimbo S, Hanson K.
    Health Aff (Millwood); 2009 Dec; 28(4):1022-33. PubMed ID: 19597201
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians.
    Pereira JA, Holbrook AM, Dolovich L, Goldsmith C, Thabane L, Douketis JD, Crowther M, Bates SM, Ginsberg JS.
    Can J Clin Pharmacol; 2005 Dec; 12(3):e229-39. PubMed ID: 16278495
    [Abstract] [Full Text] [Related]

  • 17. Use of generic cardiovascular medications by elderly Medicare beneficiaries receiving generalist or cardiologist care.
    Federman AD, Halm EA, Siu AL.
    Med Care; 2007 Feb; 45(2):109-15. PubMed ID: 17224772
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.